Global Ganja Report

The Fiscal Times is enthused by the emergence of "Pot-economics" and the "The Birth of the Legal Weed Industry" in Colorado after Amendment 64. But PBS News Hour emphasizes that "State Is Anxious Over US Government's Reaction" after the Colorado vote. Note the quote from Jerry Peters of Denver's North Metro Drug Task Force:

Prosecutors in Washington's King and Pierce counties are dismissing more than 220 misdemeanor marijuana cases in response to last week's vote to legalize small quantities of cannabis. In King County, 175 cases have been dismissed involving possession of one ounce or less. I-502 makes one ounce legal on Dec. 6, but King County Prosecutor Dan Satterberg decided to apply I-502 retroactively.  "Although the effective date of I-502 is not until December 6, there is no point in continuing to seek criminal penalties for conduct that will be legal next month," Satterberg said in a statement.

With Colorado hoping to harvest revenue from taxes and licensing fees on newly legal cannabis, the herbal enthusiasts who fought for Amendment 64 may find their fantasies of free—or at least cheap—weed dashed by the state's new marijuana order. National Public Radio on Nov. 13 features an interview with reporter Tony Dokoupil, author of a Newsweek cover story, "The New Pot Barons." He notes the restrictive system already in place for medical marijuana in the Centennial State, and warns:

Cannabis is set to become legal in Colorado and Washington after voters passed historic ballot initiatives on Nov. 6. In Washington voters approved Initiative 502, allowing possession and distribution of cannabis through a state licensing system of growers, processors and stores, where adults will be able to buy up to an ounce of dried cannabis; up to a pound of a cannabis-infused product, such as brownies; or up to 72 ounces of cannabis-infused liquids.. The Colorado initiative actually introduces Amendment 64 to the state constitution, allowing adults over 21 to possess up to an ounce and to privately grow up to six plants—although public use will be banned. In Oregon, the similar Cannabis Tax Act Initiative or Measure 80, failed by approximately 55-to-45% of the vote.

California's Fourth District Court of Appeal for California issued a unanimous ruling Oct. 24 in a landmark medical marijuana case that reverses the conviction of San Diego dispensary operator Jovan Jackson, convicted in September 2010 after being denied a defense in state court. The Fourth District ruling also reversed the lower court's finding that Jackson was not entitled to a defense, providing the elements for such a defense in future jury trials.

Less than a week after oral arguments in the landmark federal case to reclassify cannabis for medical use, the plaintiffs filed an additional brief Oct. 22 at the request of the court. In the case Americans for Safe Access v. Drug Enforcement Administration, the DC Circuit Court of Appeals issued an order last week seeking details on the harm sustained by plaintiff and disabled US Air Force veteran Michael Krawitz as a result of the federal government's policy on medical marijuana.

Oakland City Attorney Barbara Parker and San Francisco law firm Morrison & Foerster announced Oct. 11 that the City of Oakland has filed a complaint in US District Court to stop the federal government from seizing an Oakland building used by a medical marijuana dispensary. "This lawsuit is about protecting the rights of legitimate medical patients," Parker said in a statement. "I am deeply dismayed that the federal government would seek to deny these rights and deprive thousands of seriously ill Californians of access to safe, affordable and effective medicine." The civil suit, which has City Council approval, seeks to "restrain and declare unlawful" forfeiture proceedings against the landlords of the dispensary, Harborside Health Center, stating that Oakland will "suffer irreparable harm if the dispensaries are shuttered."

For the first time in nearly 20 years, a US Court of Appeals is set to hear oral arguments in a lawsuit challenging the federal government's classification of cannabis as a dangerous drug with no medicinal value: Americans for Safe Access v. Drug Enforcement Administration. This historic case will force a federal court to finally review the scientific evidence regarding the therapeutic efficacy of cannabis. During a press briefing Oct. 4, plaintiffs in the case, along with leading medical researchers and clinicians, spoke by conference call about the necessity of the federal government recognizing current scientific data supporting marijuana rescheduling. Cannabis is currently classified in the same category as heroin despite calls from scientists, medical professionals, and policy makers to reschedule the plant for medical use.